-
Location
-
29 Newbury Street, 3 Rd Floor, Boston, MA
-
Summary
-
The estimated value of insider holdings of Third Rock Ventures III, L.P. is at least $281M dollars as of February 6, 2023. Third Rock Ventures III, L.P. is the 10%+ Owner of Revolution Medicines, Inc. and owns shares of Revolution Medicines, Inc. (RVMD) stock worth about $138M. Third Rock Ventures III, L.P. is the 10%+ Owner of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $68.4M. Third Rock Ventures III, L.P. is the 10%+ Owner of Nurix Therapeutics, Inc. and owns shares of Nurix Therapeutics, Inc. (NRIX) stock worth about $35.1M. Third Rock Ventures III, L.P. is the 10%+ Owner of Voyager Therapeutics, Inc. and owns shares of Voyager Therapeutics, Inc. (VYGR) stock worth about $22.8M. Third Rock Ventures III, L.P. is the 10%+ Owner of Fulcrum Therapeutics, Inc. and owns shares of Fulcrum Therapeutics, Inc. (FULC) stock worth about $14.3M. Third Rock Ventures III, L.P. is the 10%+ Owner of Jounce Therapeutics, Inc. and owns shares of Jounce Therapeutics, Inc. stock worth about $2.65M.
-
Signature
-
/s/ Kevin Gillis, Chief Operating Officer of TRV GP III, LLC, general partner of Third Rock Ventures GP III, L.P., general partner of Third Rock Ventures III, L.P.